- MiR-1224 Acts as a Prognostic Biomarker and Inhibits the Progression of Gastric Cancer by Targeting SATB1
Guo-Dong Han et al, 2021, Frontiers in Oncology CrossRef - A Potential Target for Clinical Atherosclerosis: A Novel Insight Derived from TPM2
Ling-bing Meng et al, 2022, Aging and disease CrossRef - Aberrant DNA Methylation-Mediated FOXF2 Dysregulation Is a Prognostic Risk Factor for Gastric Cancer
Cheng Zhang et al, 2021, Frontiers in Molecular Biosciences CrossRef - Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
Qingfan Yang et al, 2022, Frontiers in Oncology CrossRef - Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer
Xingchen Zhou et al, 2024, International Journal of General Medicine CrossRef - Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
Miao Su et al, 2021, Frontiers in Genetics CrossRef - Carnosol attenuated atrophy of C2C12 myotubes induced by tumour‐derived exosomal miR‐183‐5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration
Ji‐Xia Kuang et al, 2022, Basic & Clinical Pharmacology & Toxicology CrossRef - Bioinformatics and pathway enrichment analysis identified hub genes and potential biomarker for gastric cancer prognosis
Elham Darang et al, 2023, Frontiers in Oncology CrossRef - Deciphering the significance of anoikis in bladder cancer and systematic analysis of S100A7 as a potential therapeutic target
Haoran Wang et al, 2024, European Journal of Medical Research CrossRef